Primary Urethral Carcinoma


1.Boorjian, S.A., et al. Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol, 2011. 60: 1266.

2.Witjes, J.A., et al. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Edn. presented at the 37th EAU Annual Congress Amsterdam, in EAU Guidelines 2022: Arnhem. The Netherlands.

3.Gakis, G., et al. European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update. Eur Urol Oncol, 2020. 3: 424.

4.Guyatt, G.H., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008. 336: 924.

5.Guyatt, G.H., et al. What is “quality of evidence” and why is it important to clinicians? BMJ, 2008. 336: 995.

6.Phillips, B., et al. Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009. [Access date March 2022].

7.Guyatt, G.H., et al. Going from evidence to recommendations. BMJ, 2008. 336: 1049.

8.Gatta, G., et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer, 2011. 47: 2493.

9.Brierley, J.D., et al., TNM classification of malignant tumors. UICC International Union Against Cancer. 2017, Wiley/Blackwell. p. 208.

10.RARECARENet. Surveillance of Rare Cancers in Europe. 2019. [Access date March 2022]., M., et al. Incidence rates and contemporary trends in primary urethral cancer. Cancer Causes Control, 2021. 32: 627.

12.Wenzel, M., et al. Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients. Clin Genitourin Cancer, 2021. 19: 135.

13.Krukowski, J., et al. Primary urethral carcinoma - unexpected cause of urethral stricture. Case report and review of the literature. Med Ultrason, 2019. 21: 494.

14.Guo, H., et al. Lichen Sclerosus Accompanied by Urethral Squamous Cell Carcinoma: A Retrospective Study From a Urethral Referral Center. Am J Mens Health, 2018. 12: 1692.

15.Colapinto, V., et al. Primary carcinoma of the male urethra developing after urethroplasty for stricture. J Urol, 1977. 118: 581.

16.Mohanty, N.K., et al. Squamous cell carcinoma of perineal urethrostomy. Urol Int, 1995. 55: 118.

17.Sawczuk, I., et al. Post urethroplasty squamous cell carcinoma. N Y State J Med, 1986. 86: 261.

18.Mohan, H., et al. Squamous cell carcinoma of the prostate. Int J Urol, 2003. 10: 114.

19.Arva, N.C., et al. Diagnostic dilemmas of squamous differentiation in prostate carcinoma case report and review of the literature. Diagn Pathol, 2011. 6: 46.

20.Cupp, M.R., et al. Detection of human papillomavirus DNA in primary squamous cell carcinoma of the male urethra. Urology, 1996. 48: 551.

21.Wiener, J.S., et al. Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. Cancer Res, 1992. 52: 5018.

22.Ahmed, K., et al. Urethral diverticular carcinoma: an overview of current trends in diagnosis and management. Int Urol Nephrol, 2010. 42: 331.

23.Chung, D.E., et al. Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings. J Urol, 2010. 183: 2265.

24.Thomas, A.A., et al. Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol, 2008. 180: 2463.

25.Libby, B., et al. Non-surgical treatment of primary female urethral cancer. Rare Tumors, 2010. 2: e55.

26.Altman, D., et al. Cancer Risk After Midurethral Sling Surgery Using Polypropylene Mesh. Obstet Gynecol, 2018. 131: 469.

27.Gandhi, J.S., et al. Clear cell adenocarcinoma of the male urethral tract. Indian J Pathol Microbiol, 2012. 55: 245.

28.Mehra, R., et al. Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. Am J Pathol, 2014. 184: 584.

29.Visser, O., et al. Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer, 2012.
48: 456.


30.Rabbani, F. Prognostic factors in male urethral cancer. Cancer, 2011. 117: 2426.

31.Aleksic, I., et al. Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival. Urol Ann, 2018. 10: 170.

32.Sui, W., et al. Outcomes and Prognostic Factors of Primary Urethral Cancer. Urology, 2017. 100: 180.

33.Greiman, A.K., et al. Urethral diverticulum: A systematic review. Arab J Urol, 2019. 17: 49.

34.WHO. Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Eble, J.N., Sauter, G., Epstein, J. Eds. 2004, Lyon.

35.Comperat, E., et al. Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classification. Histopathology, 2016. 69: 717.

36.Shanks, J.H., et al. Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 2019. 75: 453.

37.Gheiler, E.L., et al. Management of primary urethral cancer. Urology, 1998. 52: 487.

38.Karnes, R.J., et al. Surgery for urethral cancer. Urol Clin North Am, 2010. 37: 445.

39.Blaivas, J.G., et al. Periurethral masses: etiology and diagnosis in a large series of women. Obstet Gynecol, 2004. 103: 842.

40.Barkan, G.A., et al. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol, 2016. 60: 185.

41.Touijer, A.K., et al. Role of voided urine cytology in diagnosing primary urethral carcinoma. Urology, 2004. 63: 33.

42.Gakis, G., et al. Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urol Int, 2016. 97: 134.

43.Samm, B.J., et al. Penectomy: a technique to reduce blood loss. Urology, 1999. 53: 393.

44.Donat, S.M., et al. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol, 2001. 165: 1580.

45.Schubert, T., et al. MP11-20 The predictive accuracy between clinical staging and pathological staging in patients with primary urethral carcinoma. J Urol, 2019. 201: e135.

46.Del Gaizo, A., et al. Magnetic resonance imaging of solid urethral and peri-urethral lesions. Insights Imaging, 2013. 4: 461.

47.Itani, M., et al. MRI of female urethra and periurethral pathologies. Int Urogynecol J, 2016. 27: 195.

48.Stewart, S.B., et al. Imaging tumors of the penis and urethra. Urol Clin North Am, 2010. 37: 353.

49.Kim, B., et al. Imaging of the male urethra. Semin Ultrasound CT MR, 2007. 28: 258.

50.Raman, S.P., et al. Upper and Lower Tract Urothelial Imaging Using Computed Tomography Urography. Radiol Clin North Am, 2017. 55: 225.

51.Gourtsoyianni, S., et al. MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration. Clin Radiol, 2011. 66: 1072.

52.Laudicella, R., et al. (18)F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma. Nucl Med Mol Imaging, 2019. 53: 296.

53.Naumann, C.M., et al. Reliability of dynamic sentinel node biopsy combined with ultrasound-guided removal of sonographically suspicious lymph nodes as a diagnostic approach in patients with penile cancer with palpable inguinal lymph nodes. Urol Oncol, 2015. 33: 389.e9.

54.Dayyani, F., et al. Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol, 2013. 31: 1171.

55.Gakis, G., et al. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol, 2016. 34: 97.

56.Werntz, R.P., et al. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma. Urol Oncol, 2018. 36: 526 e1.

57.Carroll, P.R., et al. Surgical anatomy of the male and female urethra. Urol Clin North Am, 1992. 19: 339.

58.Sharp, D., et al., Surgery of penile and urethral carcinoma, in Campbell’s Urology, D. McDougal, A. Wein, L. Kavoussi, A. Novick, A. Partin, C. Peters & P. Ramchandani, Eds. 212, Saunders Elsevier: Philadelphia, PA, USA.

59.Abudurexiti, M., et al. Prognosis of rare pathological primary urethral carcinoma. Cancer Manag Res, 2018. 10: 6815.

60.Swartz, M.A., et al. Incidence of primary urethral carcinoma in the United States. Urology, 2006.
68: 1164.

61.Champ, C.E., et al. Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology, 2012. 80: 374.

62.Panettieri, V., et al. External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost. Front Oncol, 2020. 10: 910.

63.Derksen, J.W., et al. Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol, 2013. 31: 147.

64.Wenzel, M., et al. Comparison Between Urothelial and Non-Urothelial Urethral Cancer. Front Oncol, 2020. 10: 629692.

65.Stone, B.V., et al. The effect of centralization of care on overall survival in primary urethral cancer. Urol Oncol, 2021. 39: 133.

66.Gakis, G., et al. The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urol Oncol, 2018. 36: 10 e7.

67.Dalbagni, G., et al. Male urethral carcinoma: analysis of treatment outcome. Urology, 1999. 53: 1126.

68.Smith, Y., et al. Penile-preserving surgery for male distal urethral carcinoma. BJU Int, 2007. 100: 82.

69.Pedrosa, J.A., et al. Distal urethrectomy for localized penile squamous carcinoma in situ extending into the urethra: an updated series. Int Urol Nephrol, 2014. 46: 1551.

70.Kulkarni, M., et al. MP10-16 Substitution urethroplasty for treatment of distal urethral carcinoma and carcinoma in situ. J. Urol 193: e117.

71.Torbrand, C., et al. Diagnosing Distal Urethral Carcinomas in Men Might Be Only the Tip of the Iceberg. Clin Genitourin Cancer, 2017. 15: e1131.

72.Dimarco, D.S., et al. Surgical treatment for local control of female urethral carcinoma. Urol Oncol, 2004. 22: 404.

73.DiMarco, D.S., et al. Outcome of surgical treatment for primary malignant melanoma of the female urethra. J Urol, 2004. 171: 765.

74.Garden, A.S., et al. Primary carcinoma of the female urethra. Results of radiation therapy. Cancer, 1993. 71: 3102.

75.Milosevic, M.F., et al. Urethral carcinoma in women: results of treatment with primary radiotherapy. Radiother Oncol, 2000. 56: 29.

76.Zinman, L.N., et al. Management of Proximal Primary Urethral Cancer: Should Multidisciplinary Therapy Be the Gold Standard? Urol Clin North Am, 2016. 43: 505.

77.Cahn, D.B., et al. Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: A National Cancer Database Analysis. Urol Oncol, 2017. 35: 670 e15.

78.Dayyani, F., et al. Management of advanced primary urethral carcinomas. BJU Int, 2014. 114: 25.

79.Peyton, C.C., et al. Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience. Clin Genitourin Cancer, 2018. 16: e1003.

80.Mano, R., et al. Primary urethral cancer: treatment patterns and associated outcomes. BJU Int, 2020. 126: 359.

81.Gakis, G., et al. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma. Ann Oncol, 2015. 26: 1754.

82.Kent, M., et al. Combined chemoradiation as primary treatment for invasive male urethral cancer.
J Urol, 2015. 193: 532.

83.Gakis, G. Editorial Comment to Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma. Int J Urol, 2014. 21: 424.

84.Itoh, J., et al. Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma. Int J Urol, 2014. 21: 422.

85.Hara, I., et al. Successful treatment for squamous cell carcinoma of the female urethra with combined radio- and chemotherapy. Int J Urol, 2004. 11: 678.

86.Cohen, M.S., et al. Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra. J Urol, 2008. 179: 536.

87.Son, C.H., et al. Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent. Int J Radiat Oncol Biol Phys, 2018. 102: 304.

88.Palou Redorta, J., et al. Intravesical instillations with bacillus calmette-guerin for the treatment of carcinoma in situ involving prostatic ducts. Eur Urol, 2006. 49: 834.

89.Patschan, O., et al. Systematic Review of the Role of BCG in the Treatment of Urothelial Carcinoma of the Prostatic Urethra. Bladder Cancer, 2021. 7: 213.

90.Njinou Ngninkeu, B., et al. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol, 2003. 169: 149.

91.Palou, J., et al. Urothelial carcinoma of the prostate. Urology, 2007. 69: 50.

92.Hillyard, R.W., Jr., et al. Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin. J Urol, 1988. 139: 290.

93.Solsona, E., et al. The prostate involvement as prognostic factor in patients with superficial bladder tumors. J Urol, 1995. 154: 1710.

94.Vazina, A., et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens.
J Urol, 2004. 171: 1830.

95.Balar, A.V., et al. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol, 2017. 18: 1483.

96.Shukla, C.J., et al. Palliation of male genital cancers. Clin Oncol (R Coll Radiol), 2010. 22: 747.